Panbela Therapeutics Price History

PBLADelisted Stock  USD 2.06  0.11  5.07%   
If you're considering investing in Panbela Stock, it is important to understand the factors that can impact its price. As of today, the current price of Panbela Therapeutics stands at 2.06, as last reported on the 30th of November, with the highest price reaching 2.17 and the lowest price hitting 2.02 during the day. We have found twenty-four technical indicators for Panbela Therapeutics, which you can use to evaluate the volatility of the company. Please check Panbela Therapeutics' Variance of 132.71, risk adjusted performance of (0.14), and Coefficient Of Variation of (506.98) to confirm if the risk estimate we provide is consistent with the expected return of 0.0%.
  
Panbela Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
PBLA
Based on monthly moving average Panbela Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Panbela Therapeutics by adding Panbela Therapeutics to a well-diversified portfolio.

Panbela Therapeutics Stock Price History Chart

There are several ways to analyze Panbela Stock price data. The simplest method is using a basic Panbela candlestick price chart, which shows Panbela Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.

Panbela Stock Price History Data

The price series of Panbela Therapeutics for the period between Sun, Sep 1, 2024 and Sat, Nov 30, 2024 has a statistical range of 14.75 with a coefficient of variation of 65.92. The price distribution for the period has arithmetic mean of 7.65. The median price for the last 90 days is 6.75. The company completed stock split (1:20) on 18th of January 2024. Panbela Therapeutics had dividends distributed to its stock-holders on 2017-11-08.
OpenHighLowCloseVolume
11/30/2024
 2.17  2.17  2.02  2.06 
07/24/2023 2.17  2.17  2.02  2.06  579,900 
07/21/2023 2.29  2.30  2.08  2.17  479,700 
07/20/2023 2.15  2.34  2.08  2.23  1,069,361 
07/19/2023 2.33  3.07  2.15  2.17  45,088,061 
07/18/2023 2.06  2.14  2.02  2.07  54,866 
07/17/2023 2.14  2.14  2.03  2.08  74,800 
07/14/2023 2.09  2.12  2.03  2.08  67,491 
07/13/2023 2.30  2.30  2.03  2.07  253,659 
07/12/2023 2.27  2.39  2.16  2.23  193,536 
07/11/2023 2.40  2.44  2.14  2.29  300,683 
07/10/2023 2.20  2.45  2.14  2.38  743,958 
07/07/2023 2.18  2.18  2.10  2.15  77,232 
07/06/2023 2.30  2.30  2.13  2.17  125,500 
07/05/2023 2.19  2.30  2.12  2.30  139,449 
07/03/2023 2.29  2.29  2.09  2.19  166,045 
06/30/2023 2.08  2.42  2.00  2.30  1,317,208 
06/29/2023 2.22  2.24  2.05  2.09  95,918 
06/28/2023 2.06  2.27  2.00  2.22  476,900 
06/27/2023 2.02  2.09  1.80  2.06  342,292 
06/26/2023 2.26  2.28  2.00  2.05  475,989 
06/23/2023 2.32  2.32  2.19  2.24  204,743 
06/22/2023 2.34  2.39  2.20  2.33  349,900 
06/21/2023 2.32  2.37  2.24  2.30  163,835 
06/20/2023 2.63  2.66  2.14  2.27  838,044 
06/16/2023 2.79  2.90  2.27  2.60  2,510,493 
06/15/2023 5.52  6.50  5.35  5.81  279,315 
06/14/2023 6.13  6.69  5.40  5.60  289,460 
06/13/2023 7.36  9.04  5.82  6.15  932,111 
06/12/2023 6.99  6.99  6.25  6.50  62,211 
06/09/2023 7.14  7.68  6.75  6.93  91,376 
06/08/2023 6.33  7.26  5.80  7.13  300,775 
06/07/2023 5.44  8.30  5.44  7.04  365,116 
06/06/2023 5.92  6.01  5.00  5.44  171,352 
06/05/2023 6.14  6.41  5.93  5.95  86,735 
06/02/2023 7.18  8.49  6.52  6.58  390,718 
06/01/2023 7.32  8.50  5.91  6.36  286,189 
05/31/2023 7.50  8.64  6.30  6.75  130,433 
05/30/2023 10.08  10.50  9.84  10.20  11,623 
05/26/2023 0.37  10.08  10.08  10.08  23,234 
05/25/2023 0.38  10.80  10.80  10.80  13,294 
05/24/2023 0.39  11.33  11.33  11.33  9,772 
05/23/2023 0.39  11.97  11.97  11.97  9,286 
05/22/2023 0.38  11.53  11.53  11.53  12,172 
05/19/2023 0.40  11.40  11.40  11.40  8,757 
05/18/2023 0.39  12.00  12.00  12.00  7,819 
05/17/2023 0.39  11.65  11.65  11.65  6,587 
05/16/2023 0.40  11.64  11.64  11.64  8,986 
05/15/2023 0.37  12.30  12.30  12.30  15,969 
05/12/2023 0.38  11.40  11.40  11.40  18,347 
05/11/2023 0.40  11.41  11.41  11.41  17,817 
05/10/2023 0.39  12.26  12.26  12.26  22,131 
05/09/2023 0.40  11.85  11.85  11.85  50,604 
05/08/2023 0.43  14.84  14.84  14.84  48,205 
05/05/2023 0.41  13.05  13.05  13.05  27,359 
05/04/2023 0.46  13.50  13.50  13.50  19,161 
05/03/2023 0.41  14.56  14.56  14.56  29,744 
05/02/2023 0.44  13.50  13.50  13.50  37,975 
05/01/2023 0.51  13.62  13.62  13.62  61,947 
04/28/2023 0.50  16.47  16.47  16.47  67,574 
04/27/2023 0.49  15.90  15.90  15.90  129,542 

About Panbela Therapeutics Stock history

Panbela Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Panbela is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Panbela Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Panbela Therapeutics stock prices may prove useful in developing a viable investing in Panbela Therapeutics
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota. Panbela Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.

Panbela Therapeutics Stock Technical Analysis

Panbela Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Panbela Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Panbela Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Idea Optimizer Now

   

Idea Optimizer

Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
All  Next Launch Module

Panbela Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Panbela Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Panbela Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Panbela to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Panbela Stock

If you are still planning to invest in Panbela Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Panbela Therapeutics' history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing